These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 443696)
1. Bromocriptine and pituitary disorders. Kellett J; Friesen HG Ann Intern Med; 1979 Jun; 90(6):980-2. PubMed ID: 443696 [No Abstract] [Full Text] [Related]
2. Bromocriptine in pituitary tumours. Corenblum B Lancet; 1978 Oct; 2(8093):786. PubMed ID: 80708 [No Abstract] [Full Text] [Related]
3. Regression of pituitary prolactinoma after treatment with bromocriptine. Landolt AM; Wüthrich R; Fellmann H Lancet; 1979 May; 1(8125):1082-3. PubMed ID: 86800 [No Abstract] [Full Text] [Related]
4. Hyperprolactinemia. Morphologic and clinical considerations. Ezrin C; Kovacs K; Horvath E Med Clin North Am; 1978 Mar; 62(2):393-408. PubMed ID: 205742 [No Abstract] [Full Text] [Related]
5. Endocrine and metabolic diseases. Pituitary diseases. Strong JA Br Med J; 1976 Mar; 1(6010):640-2. PubMed ID: 175879 [No Abstract] [Full Text] [Related]
6. A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma. Van Loon GR Lancet; 1978 Oct; 2(8095):868-71. PubMed ID: 81414 [TBL] [Abstract][Full Text] [Related]
7. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report. Crosignani PG; Mattei A; Ferrari C; Giovanelli MA Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250 [TBL] [Abstract][Full Text] [Related]
8. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas. Landolt AM; Minder H; Osterwalder V; Landolt TA Experientia; 1983 Jun; 39(6):625-6. PubMed ID: 6852202 [TBL] [Abstract][Full Text] [Related]
9. New drugs in the treatment of pituitary disorders. Van Loon GR Prim Care; 1977 Dec; 4(4):721-37. PubMed ID: 337337 [TBL] [Abstract][Full Text] [Related]
10. Report of the National Symposium on the Clinical Management of Prolactin-Related Reproductive Disorders. Blackwell RE; Chang RJ Fertil Steril; 1986 May; 45(5):607-10. PubMed ID: 3699168 [No Abstract] [Full Text] [Related]
11. Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1. Hershon KS; Kelly WA; Shaw CM; Schwartz R; Bierman EL Am J Med; 1983 Apr; 74(4):713-20. PubMed ID: 6837595 [TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and endocrine disorders. Spark RF; Dickstein G Ann Intern Med; 1979 Jun; 90(6):949-56. PubMed ID: 443691 [TBL] [Abstract][Full Text] [Related]
13. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas? Landolt AM; Keller PJ; Froesch ER; Mueller J Lancet; 1982 Sep; 2(8299):657-8. PubMed ID: 6125789 [No Abstract] [Full Text] [Related]
14. Drugs five years later. Bromocriptine. Vance ML; Evans WS; Thorner MO Ann Intern Med; 1984 Jan; 100(1):78-91. PubMed ID: 6229205 [TBL] [Abstract][Full Text] [Related]
15. Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine. Ayers JW Fertil Steril; 1983 Dec; 40(6):846-8. PubMed ID: 6653805 [No Abstract] [Full Text] [Related]